NCT03035084View on ClinicalTrials.gov

Is Vitamin D2 Treatment-associated Decrease in 25(OH)D3 Level a Reciprocal Phenomena?

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 15, 2017

Primary Completion Date

November 20, 2017

Study Completion Date

November 20, 2017

Conditions
Vitamin D Deficiency25-Hydroxyvitamin D Concentration
Interventions
DRUG

Vitamin D3

Single oral dose of 50,000 IU of vitamin D3

DRUG

Vitamin D2

Single oral dose of 50,000 IU of vitamin D2

DRUG

Placebo oral capsule

Placebo oral capsule

Trial Locations (1)

11211

King Faisal Specialist Hospital & Research Center, Riyadh

All Listed Sponsors
lead

King Faisal Specialist Hospital & Research Center

OTHER

NCT03035084 - Is Vitamin D2 Treatment-associated Decrease in 25(OH)D3 Level a Reciprocal Phenomena? | Biotech Hunter | Biotech Hunter